133 related articles for article (PubMed ID: 37655363)
1. Automatic covariance pattern analysis outperforms visual reading of
Buchert R; Wegner F; Huppertz HJ; Berding G; Brendel M; Apostolova I; Buhmann C; Dierks A; Katzdobler S; Klietz M; Levin J; Mahmoudi N; Rinscheid A; Rogozinski S; Rumpf JJ; Schneider C; Stöcklein S; Spetsieris PG; Eidelberg D; Wattjes MP; Sabri O; Barthel H; Höglinger G;
Mov Disord; 2023 Oct; 38(10):1901-1913. PubMed ID: 37655363
[TBL] [Abstract][Full Text] [Related]
2. Brain MRI in Progressive Supranuclear Palsy with Richardson's Syndrome and Variant Phenotypes.
Wattjes MP; Huppertz HJ; Mahmoudi N; Stöcklein S; Rogozinski S; Wegner F; Klietz M; Apostolova I; Levin J; Katzdobler S; Buhmann C; Quattrone A; Berding G; Brendel M; Barthel H; Sabri O; Höglinger G; Buchert R;
Mov Disord; 2023 Oct; 38(10):1891-1900. PubMed ID: 37545102
[TBL] [Abstract][Full Text] [Related]
3. Multicenter Validation of Metabolic Abnormalities Related to PSP According to the MDS-PSP Criteria.
Martí-Andrés G; van Bommel L; Meles SK; Riverol M; Valentí R; Kogan RV; Renken RJ; Gurvits V; van Laar T; Pagani M; Prieto E; Luquin MR; Leenders KL; Arbizu J
Mov Disord; 2020 Nov; 35(11):2009-2018. PubMed ID: 32822512
[TBL] [Abstract][Full Text] [Related]
4. Brain FDG-PET correlates of saccadic disorders in early PSP.
Pin G; Labouré J; Guedj E; Felician O; Grimaldi S; Azulay JP; Ceccaldi M; Koric L
J Neurol; 2023 Oct; 270(10):4841-4850. PubMed ID: 37330976
[TBL] [Abstract][Full Text] [Related]
5. Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy.
Brendel M; Barthel H; van Eimeren T; Marek K; Beyer L; Song M; Palleis C; Gehmeyr M; Fietzek U; Respondek G; Sauerbeck J; Nitschmann A; Zach C; Hammes J; Barbe MT; Onur O; Jessen F; Saur D; Schroeter ML; Rumpf JJ; Rullmann M; Schildan A; Patt M; Neumaier B; Barret O; Madonia J; Russell DS; Stephens A; Roeber S; Herms J; Bötzel K; Classen J; Bartenstein P; Villemagne V; Levin J; Höglinger GU; Drzezga A; Seibyl J; Sabri O
JAMA Neurol; 2020 Nov; 77(11):1408-1419. PubMed ID: 33165511
[TBL] [Abstract][Full Text] [Related]
6. [¹⁸F]FDG-PET is superior to [¹²³I]IBZM-SPECT for the differential diagnosis of parkinsonism.
Hellwig S; Amtage F; Kreft A; Buchert R; Winz OH; Vach W; Spehl TS; Rijntjes M; Hellwig B; Weiller C; Winkler C; Weber WA; Tüscher O; Meyer PT
Neurology; 2012 Sep; 79(13):1314-22. PubMed ID: 22914831
[TBL] [Abstract][Full Text] [Related]
7. Midbrain MRI assessments in progressive supranuclear palsy subtypes.
Picillo M; Tepedino MF; Abate F; Erro R; Ponticorvo S; Tartaglione S; Volpe G; Frosini D; Cecchi P; Cosottini M; Ceravolo R; Esposito F; Pellecchia MT; Barone P; Manara R
J Neurol Neurosurg Psychiatry; 2020 Jan; 91(1):98-103. PubMed ID: 31527182
[TBL] [Abstract][Full Text] [Related]
8. The utility of FDG-PET in the differential diagnosis of Parkinsonism.
Brajkovic L; Kostic V; Sobic-Saranovic D; Stefanova E; Jecmenica-Lukic M; Jesic A; Stojiljkovic M; Odalovic S; Gallivanone F; Castiglioni I; Radovic B; Trajkovic G; Artiko V
Neurol Res; 2017 Aug; 39(8):675-684. PubMed ID: 28378615
[TBL] [Abstract][Full Text] [Related]
9. Familial progressive supranuclear palsy: detection of subclinical cases using 18F-dopa and 18fluorodeoxyglucose positron emission tomography.
Piccini P; de Yebenez J; Lees AJ; Ceravolo R; Turjanski N; Pramstaller P; Brooks DJ
Arch Neurol; 2001 Nov; 58(11):1846-51. PubMed ID: 11708994
[TBL] [Abstract][Full Text] [Related]
10. Reproducible network and regional topographies of abnormal glucose metabolism associated with progressive supranuclear palsy: Multivariate and univariate analyses in American and Chinese patient cohorts.
Ge J; Wu J; Peng S; Wu P; Wang J; Zhang H; Guan Y; Eidelberg D; Zuo C; Ma Y
Hum Brain Mapp; 2018 Jul; 39(7):2842-2858. PubMed ID: 29536636
[TBL] [Abstract][Full Text] [Related]
11. Transcranial sonography and [18F]fluorodeoxyglucose positron emission tomography for the differential diagnosis of parkinsonism: a head-to-head comparison.
Hellwig S; Reinhard M; Amtage F; Guschlbauer B; Buchert R; Tüscher O; Weiller C; Niesen WD; Meyer PT
Eur J Neurol; 2014 Jun; 21(6):860-6. PubMed ID: 24602186
[TBL] [Abstract][Full Text] [Related]
12. Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET.
Juh R; Kim J; Moon D; Choe B; Suh T
Eur J Radiol; 2004 Sep; 51(3):223-33. PubMed ID: 15294329
[TBL] [Abstract][Full Text] [Related]
13. 18F-FDG PET Is an Early Predictor of Overall Survival in Suspected Atypical Parkinsonism.
Hellwig S; Frings L; Amtage F; Buchert R; Spehl TS; Rijntjes M; Tüscher O; Weiller C; Weber WA; Vach W; Meyer PT
J Nucl Med; 2015 Oct; 56(10):1541-6. PubMed ID: 26229141
[TBL] [Abstract][Full Text] [Related]
14. Differential diagnosis of parkinsonian syndromes using F-18 fluorodeoxyglucose positron emission tomography.
Tripathi M; Dhawan V; Peng S; Kushwaha S; Batla A; Jaimini A; D'Souza MM; Sharma R; Saw S; Mondal A
Neuroradiology; 2013 Mar; 55(4):483-92. PubMed ID: 23314836
[TBL] [Abstract][Full Text] [Related]
15. MRI Outperforms [18F]AV-1451 PET as a Longitudinal Biomarker in Progressive Supranuclear Palsy.
Whitwell JL; Tosakulwong N; Schwarz CG; Botha H; Senjem ML; Spychalla AJ; Ahlskog JE; Knopman DS; Petersen RC; Jack CR; Lowe VJ; Josephs KA
Mov Disord; 2019 Jan; 34(1):105-113. PubMed ID: 30468693
[TBL] [Abstract][Full Text] [Related]
16. Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants.
Whitwell JL; Tosakulwong N; Botha H; Ali F; Clark HM; Duffy JR; Utianski RL; Stevens CA; Weigand SD; Schwarz CG; Senjem ML; Jack CR; Lowe VJ; Ahlskog JE; Dickson DW; Josephs KA
Neuroimage Clin; 2020; 25():102152. PubMed ID: 31935638
[TBL] [Abstract][Full Text] [Related]
17. [A study on the cerebral glucose metabolism in progressive supranuclear palsy].
Ma AJ; Guo XJ; Li DC; Zhang BS; Pan XD
Zhonghua Nei Ke Za Zhi; 2012 Nov; 51(11):885-8. PubMed ID: 23291028
[TBL] [Abstract][Full Text] [Related]
18. Symptomatology in 4-repeat tauopathies is associated with data-driven topology of [
Schönecker S; Palleis C; Franzmeier N; Katzdobler S; Ferschmann C; Schuster S; Finze A; Scheifele M; Prix C; Fietzek U; Weidinger E; Nübling G; Vöglein J; Patt M; Barthel H; Sabri O; Danek A; Höglinger GU; Brendel M; Levin J;
Neuroimage Clin; 2023; 38():103402. PubMed ID: 37087820
[TBL] [Abstract][Full Text] [Related]
19. A disease-specific metabolic brain network associated with corticobasal degeneration.
Niethammer M; Tang CC; Feigin A; Allen PJ; Heinen L; Hellwig S; Amtage F; Hanspal E; Vonsattel JP; Poston KL; Meyer PT; Leenders KL; Eidelberg D
Brain; 2014 Nov; 137(Pt 11):3036-46. PubMed ID: 25208922
[TBL] [Abstract][Full Text] [Related]
20. Fluorodeoxyglucose positron emission tomography in Richardson’s syndrome and progressive supranuclear palsy-parkinsonism.
Srulijes K; Reimold M; Liscic RM; Bauer S; Dietzel E; Liepelt-Scarfone I; Berg D; Maetzler W
Mov Disord; 2012 Jan; 27(1):151-5. PubMed ID: 22359740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
